By Alex Philippidis

NEW YORK (GenomeWeb News) – Duke University Medical Center has opened a $5.3 million facility designed to apply systems biology and molecular medicine approaches to early-phase studies of new drug or medical device candidates, especially at the proof-of-concept or "first-in-human" clinical stages.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.